经皮肺动脉瓣植入术的现状及未来展望

近年来，随着医学技术的进步，接受经皮肺动脉瓣植入术的患者数量不断增加，目前经皮肺动脉瓣植入术（PPVI）被认为是一种安全、有效、被国内外广泛接受的治疗患有右室流出道（RVOT）功能障碍的新方法。现临床主要应用Melody瓣膜、Sapien瓣膜和Venus-P瓣膜，依据RVOT直径大小选用不同的瓣膜。术后并发症主要包括支架断裂、感染性心内膜炎、冠状动脉及主动脉狭窄、瓣膜栓塞、肺动脉阻塞等。现就经皮肺动脉瓣植入术的现状及未来展望做一综述，以期为临床治疗提供一定的理论依据。

Current situation and future prospect of percutaneous pulmonary valve implantation

With the progress of medical technology, the number of patients receiving percutaneous pulmonary valve implantation (PPVI) has been increasing in recent years. At present, PPVI is considered to be a safe, effective and widely accepted new method for the treatment of RVOT dysfunction at home and abroad.Now, the Melody valve, the Sapien valve and the Venus-P valves are mainly used clinically, and different valves are selected according to the RVOT diameter size.Postoperative complications mainly include stent fracture, infectious endocarditis, coronary artery and aortic stenosis, valve embolism, pulmonary artery obstruction, etc.T his article reviews the current situation and future prospect of percutaneous pulmonary valve implantation in order to provide some theoretical basis for clinical treatment.